Introduction
Twenty per cent of pediatric pre-B cell acute lymphoblastic leukemia (ALL) contain E2a-Pbx1, a chimeric oncoprotein produced by the t(1;19) translocation (Carroll et al., 1984; Williams et al., 1984; Kamps et al., 1990; Nourse et al., 1990) . This translocation fuses exons encoding two transactivation domains of E2a (Quong et al., 1993) to exons encoding the HD protein, Pbx1, beginning at residue 89. E2A encodes a basic helix ± loop ± helix transcription factor required for proper B cell development (Bain et al., 1994) , and is expressed in most embryonic and adult tissues (Roberts et al., 1993) , while PBX1 prototypes a family of three related homeobox genes, including PBX2, and PBX3 (Monica et al., 1991) , and is expressed in most fetal and adult tissues, but not in lymphoid cell lines (Kamps et al., 1990; Monica et al., 1991; Roberts et al., 1995) . Replacement of the DNA-binding domain of E2a with the Pbx1 HD and¯anking sequences creates an oncoprotein that induces inappropriate expression of tissue-speci®c genes (Fu and Kamps, 1997; McWhirter et al., 1997) , transforms NIH3T3 ®broblasts (Kamps et al., 1991) , produces acute myeloid leukemia (AML; Kamps and Baltimore, 1993) and T-cell ALL (Dedera et al., 1993) in mice, and arrests dierentiation of factor-dependent myeloid progenitors from marrow (Kamps and Wright, 1994) . Immortalization (dierentiation arrest) of mouse myeloid progenitors is the only in vitro hematopoietic assay of the leukemic function of E2a-Pbx1, and occurs with single-hit kinetics (Kamps and Wright, 1994) .
Extradentical (EXD) is the Drosophila homolog of PBX genes, and EXD mutant embryos exhibit inappropriate transcriptional regulation of the genetic targets of Homeotic Complex genes (Rauskolb et al., 1993; Rauskolb and Wieschaus 1994) . This observation led to the discovery that Pbx/Exd proteins heterodimerize cooperatively with Hox proteins (Van Dijk and Murre, 1994; Chan et al., 1994) and Engrailed proteins (Peletenburg and Murre, 1997) on TGATT-NAT elements (Lu et al., 1995; Chang et al., 1996; Lu and Kamps, 1997; Shen et al., 1997) as well as with a cellular factor ®rst dubbed NFPP (Nuclear Factor Pbx Partner; and later demonstrated to be members of the Meis and Prep1 family of HD proteins on TGATTGA-CAG elements. Meis/Prep1 are the eucaryotic cognates of the Drosophila gene, Hth, which is required for pattern formation by Hox genes (Rieckhof et al., 1997) , binds Exd in the absence of DNA, and is required for nuclear localization of Exd (Pai et al., 1998) . In all heterodimers, Pbx/Exd binds the 5'TGAT core (Lu et al., 1995; Chan et al., 1994) and stabilizes DNA-binding by Hox and Meis to their 3' sites by more than 100-fold (Lu et al., 1995; . In the Hox-Pbx-DNA complex, the Hox protein binds the Pbx1 HD Green et al., 1998; Passner et al., 1999; Piper et al., 1999) using a four to eight residue tryptophan-containing Pbxinteraction motif (the W-PIM motif). Meis/Prep1, which fails to heterodimerize with E2a-Pbx1, binds an N-terminal Pbx domain using a region in their Nterminus that we designate the Meis/Prep1 Pbxinteraction motif (MP-PIM). Pbx3 uses a third uncharacterized interaction surface, which we will designate the Pbx-speci®c Pbx-interaction motif (P-PIM) to homodimerize on TGATTGATTTGAT (Neuteboom and Murre, 1997) . Heterodimers of Pbx proteins with HoxB1 and Stf-1 contribute to transcriptional activation of the HoxB1 and Somatostatin genes, respectively (PoÈ pperl et al., 1995; Di Rocco et al., 1997; Peers et al., 1995) . Pbx-Meis/Prep1 heterodimers cooperate with other transcription factors in activation of the uPA (Berthelsen et al., 1998a,b; De Cesare et al., 1997) and bovine CYP17a promoters (Bischof et al., 1998) , and synergize with Oct-1 in both transcriptional activation and glucocorticoid-induced repression of the prolactin gene (Subramaniam et al., 1997 (Subramaniam et al., , 1998 . Synergistic interactions between Pbx, Hox and Meis proteins has recently been reported. Pbx-Prep complexes cooperate with a Stf-1 binding site in activating Somatostatin transcription through a proximal enhancer (Goudet et al., 1999) , and Pbx-HoxB1 complexes cooperate with a Meis binding motif to activate HoxB2 transcription through the r4 enhancer (Jacobs et al., 1999) .
Both the nuclear location and DNA-binding activity of Pbx proteins are negatively regulated by intrinsic mechanisms derepressed by interaction with other HD proteins and DNA. Despite the nuclear localization sequence (NLS) contained within its HD, Exd/Pbx1 is retained in the cytoplasm by active nuclear export sensitive to Leptomycine B, an antibiotic that blocks the CRM1/exportin1 export pathway (Abu-Shaar et al., 1999; Berthelsen et al., 1999) . Nuclear export requires the function of 52 residues N-terminal of the HD (Abu-Shaar et al., 1999) . Similar to nuclear localization, monomeric DNA-binding by Pbx proteins and E2a-Pbx1 is repressed by a domain N-terminal to the HD . Here, we identify a negative regulatory switch preceding the Pbx1 HD that inhibits DNA-binding and is derepressed by heterodimer partners only in the presence of additional discrete N-terminal sequences. We report the existence of a common Pbx-dimerization surface within the switch domain. Sequences inhibiting DNA-binding and mediating Pbx-dimerization are located within the same 52 residues reported to mediate nuclear export, implicating their potential role in subcellular localization. The negative switch domain is dispensable for myeloid immortalization by E2a-Pbx1. We also report that both the 3 10 helix and a-helix C-terminal to the HD (Piper et al., 1999; Figure 1d ) are dispensable for heterodimerization of E2a-Pbx1 with multiple Hox proteins, for cooperation with Hox proteins in transcriptional activation and for blocking myeloid dierentiation. Because the Pbx1 HD alone is essential for myeloid immortalization and because Hox proteins are the only known E2a-Pbx1 partners that can heterodimerize with the HD alone we predict that Hox proteins ± or a yet unde®ned factor that binds the Pbx1 HD and derepresses DNA-binding by the HD ± are obligate partners with E2a-Pbx1 in myeloid immortalization.
Results
Twenty-five amino acids N-terminal to the Pbx1 HD inhibit its binding to DNA Formerly, we reported that addition of N-terminal sequences to S193 prevented the Pbx1 HD/C-terminus (Pbx1 D232 ± Q347 ) from binding DNA as a monomer or heterodimerizing with HoxA5 . A panel of Pbx1 mutants containing progressive Nterminal additions to Pbx1 D232 ± Q347 was constructed to test the speci®city of these inhibitory sequences, and to map their precise boundary (Figures 1b,c) . Pbx1 K216 ± Q347 bound DNA monomerically almost as well as Pbx1 D232 ± Q347 (Figure 2a , lane 10 vs 11); however, proteins initiating at K195 or seven sites N terminal to K195 failed to bind DNA (lanes 1 ± 9), demonstrating the speci®city of the inhibitory sequence. Initiation at R206 (Pbx1 R206 ± Q347 , Figure 2b , lane 3 vs 4) also prevented DNA-binding, and R206-L231, a predicted a-helix, was designated the inhibitory helix (IH).
We hypothesized that the IH could block DNAbinding by binding the 63 residue HD, or by binding and inactivating the stabilizing function of the cooperativity helices (CH; the 3 10 helix and a-helix in residues 295 ± 304; Figure 1d ), which¯ank the Cterminal edge of the Pbx1 HD and bind the HD (Piper et al., 1999) . To discriminate between these alternatives we tested whether the IH prevents DNA-binding by the isolated Pbx1 HD. Indeed, the IH also prevented weak DNA-binding by the Pbx1 HD (Pbx1 D232 ± G296 ; Figure  2b , lanes 6 ± 8), indicating it suppresses DNA-binding by direct eects on the HD. Eight point mutants and ten double point mutants were introduced within the IH of Pbx1 S202 ± Q347 (Table 1) . While Pbx1 S202 ± Q347 demonstrated less than 1% the monomeric DNAbinding activity of Pbx1 D232 ± Q347 , mutations increased monomeric DNA-binding up to 15% that of Pbx1 D232 ± Q347 ; however, in no case was IH function completely abrogated. In the context of E2a-Pbx1, deleting sequences encompassing the IH increased monomeric DNA-binding ( Figure 4b , top panel; E2a-Pbx1D 487 ± 623 , lane 4) while deleting sequences upstream of the IH did not (E2a-Pbx1D 487 ± 578 ; lane 3).
The behavior of HD point mutant E28R provided independent evidence that the IH binds the HD. Previously we found that mutation E28R blocked cooperative DNA-binding by Pbx1 D232 ± Q347 and HoxA5. To arm that E28R consistently alters HD conformation, its impact on heterodimerization with HoxB7, HoxB8, and HoxD10 was compared with that on HoxA5 (Figure 2c ). Heterodimerization with each Hox protein was reduced over tenfold. Strikingly, mutation E28R also restored active monomeric DNA-binding to Pbx1 S202 ± Q347 (Figure 2b , lane 10 vs 2) while not altering DNA-binding of Pbx1 D232-Q347 (lane 9 vs 5). The fact that a conformational change in the HD disrupts IH function independently suggests the IH binds the HD (Figure 1d ).
The IH is a dominant inhibitor of heterodimerization, requiring distinct N-terminal extensions to permit partner-dependent DNA-binding Addition of the IH to Pbx1 D232 ± G296 (Figure 2d , lane 8 vs 10) or to Pbx1 D232 ± Q347 (lane 5 vs 7) nearly abolished heterodimerization with HoxA5. Among the 18 point and double point mutants introduced within the IH of Pbx1 S202 ± Q347 (Table 1), those that increased monomeric DNA-binding also increased dimerization with HoxA5, indicating that the IH blocks heterodimerization by blocking DNA-binding (data not shown).
To map the minimal sequences required to derepress IH function, N-terminal extension mutants in Pbx1b were evaluated for their ability to heterodimerize with Hox and Prep1 partners. Restoration of full cooperative DNA-binding with HoxA5, HoxB7, HoxB8, and HoxC8 required Pbx1 sequences initiating at D55 (Figure 2e ). Initiation at D55 restored both DNAindependent binding to Prep1 (co-IP in Figure 2e ) and heterodimerization with Prep1 on TGATTGAC. Thus, Hox proteins, like Prep1, required a speci®c determinant N-terminal to the HD to evoke a conformational change permitting DNA-binding. The IH and Nterminal domain required for dimerization with Hox and Prep1 proteins functions as an inhibitory switch, where a switch in conformation coincident with heterodimerization permits DNA-binding.
The inhibitory switch contains a general Pbx dimerization motif, previously reported to exist specifically in Pbx3
In contrast to reports that Pbx1 and Pbx2 lack the novel ability of Pbx3 to homodimerize on TGATT-GATTTGAT (Neuteboom and Murre, 1997), we found that both dierentially spliced forms of Pbx1 (1a and 1b), which dier in sequences C-terminal to the HD, homodimerized on TGATTGATTTGAT as eciently as did Pbx3 ( Figure 3a , lanes 2 ± 4). The amount of E2a-Pbx1 produced in coupled transcription/translation was one-quarter that of Pbx1, and it also bound well as a homodimer (lane 6), and formed heterodimers with Pbx3, Pbx1a, or Pbx1b (lanes 7 ± 9). Antibodies to E2a failed to super-shift Pbx1a homodimers (lane 12 vs 11), supershifted monomers and homodimers of E2a-Pbx1 (lane 14 vs 13), and shifted heterodimers of E2a-Pbx1 and Pbx1a without aecting Pbx1a homodimers (lane 16 vs 15), con®rming the predicted dimer compositions. The properties of Pbx1 K216 ± Q347 and Pbx1 D232 ± Q347 con®rmed that Pbx1, like Pbx3, binds TGATT-GATTTGAT as a dimer. Each protein formed a single complex with TGATTGAT and yielded no Figure 3b , lanes 2 ± 4). By contrast, each protein bound TGATT-GATTTGAT both as monomers and as a higher order complex (lanes 6 and 7), and formed one new complex of intermediate mobility when mixed, indicating that the higher order complex is a noncooperative dimer (lane 8). The same N-terminal extension series used to identify the minimal domain required to derepress IH function for Hox and Prep1 partners was used to identify the minimal domain required for Pbx dimerziation. N-terminal residues required for cooperative homodimerization were mapped to Y168 (Figure 3c ; lanes 1 ± 12, 16 ± 19). In E2a-Pbx1, deletion of Pbx1 sequences from the E2a/Pbx1 junction to the equivalent of L183 or S209 (E2a-Pbx1D 487 ± 578 and E2a-Pbx1D 487 ± 604 , respectively) suppressed, then abolished dimerization (Figure 3d, lanes 2 and 3) , indicating that Y168-S209 contains an essential Pbx dimerization sequence (designated P-PIM; Figure 1d The inhibitory switch in E2a-Pbx1 is dispensable for cooperative transactivation with Hox proteins and for myeloid immortalization E2a-Pbx1 exhibits two distinct transactivation functions, each detected in Nalm-6 pre-B cells. E2a-Pbx1 requires coexpression of Hox proteins to activate transcription through 66TGATTTAT but activates transcription through 66TGATTGAT independent of Hox protein coexpression through an unidenti®ed mechanism (Lu and Kamps, 1997) . Independent activation through 66TGATTGAT is not likely to be mediated by cooperation with endogenous Hox proteins. All Hox proteins tested to date ± even if they prefer to heterodimerize with E2a-Pbx1 on TGATT-GAT elements ± activate transcription strongly with E2a-Pbx1 on the 66TGATTTAT reporter in Nalm-6 Figure 2 Mapping the IH and derepression domains of Pbx1. All panels represent electrophoretic mobility shift analysis of proteins produced in vitro by coupled transcription/translation. Equivalent molar quantities of all recombinant proteins were used based on analysis of parallel transcription/translation reactions performed in the presence of 35 S-methionine. All forms of Pbx1 are in the context of the Pbx1b C-terminus. (a) Mapping the location of minimal N-terminal sequences required to prevent strong monomeric DNA-binding by Pbx1 D232 ± Q347 . The complex bound by Pbx1 D232 ± Q347 is designated as a monomer based on the fact that it comigrates with recombinant Pbx1 D232 ± Q347 bound to a true half-site probe that contains TGATT as the only recognition element. The protein in this complex also fails to form complexes of intermediate size when mixed with Pbx1 K216 ± Q347 (see Figure  3) . (b) The minimal IH prevents DNA-binding by the Pbx1 HD and is functionally inhibited by HD mutation E28R. (c) Pbx1 HD mutation E28R disrupts heterodimerization of Pbx1 D232 ± Q347 with HoxA5, HoxB7, HoxB8 and HoxC8 without disrupting DNAbinding. (d) The minimal N-terminal inhibitory sequences prevent heterodimerization with Hox proteins and can be derepressed by inclusion of residues N-terminal to K195. (e) Eciency of heterodimerization of N-terminal Pbx1 mutants with HoxC8, HoxB7, Prep1, and Pbx1b. FL refers to full length Pbx1b. Inset in Prep1 bar graph represents binding of Pbx1 N-terminal mutants to Prep1 in the absence of DNA, using coimmunoprecipitation with antibodies to Pbx1. DNA motifs used to identify heterodimers were TGATTTAT for Pbx1b plus HoxC8 or HoxB7; TGATTGACAG for Pbx1b plus Prep1; and TGATTGATTTGAT for Pbx1b. The identity of complexes in (a ± e) are indicated at left, and migration of the non-speci®c complex is indicated by a ®lled circle pre-B cells. Therefore, if activation of the 66TGATT-GAT reporter by E2a-Pbx1 were accomplished in conjunction with an endogenous Hox protein, these factors should also activate transcription through the 66TGATTTAT reporter. Because no activation of the 66TGATTTAT reporter is observed by expression of E2a-Pbx1 alone, we hypothesize activation through the 66TGATTGA is accomplished by a Hox-independent mechanism. The inhibitory switch in Pbx1 was excised in E2a-Pbx1D 487 ± 623 , producing a protein similar to that of an alternative t(1;19) E2a-Pbx1 chimera in pre-B ALL (Numata et al., 1993) . The only known partners whose interaction surface on Pbx1 is retained in E2a-Pbx1D 487 ± 623 are Hox proteins. E2a-Pbx1D 487 ± 623 bound DNA actively as a monomer and bound cooperatively with Hox proteins in vitro (Figure 4b , lane 4), activated transcription cooperatively with Hox proteins in Nalm-6 cells, and immortalized myeloid progenitors (Figure 4a) . In an attempt to eliminate heterodimerization with Hox proteins, a second inhibitory switch mutant retaining the IH (E2a-Pbx1D 487 ± 578 ) was characterized. E2a-Pbx1D 487 ± 578 exhibited poor cooperative DNA-binding with Hox The CH cannot block myeloid differentiation in the absence of the HD and is fully dispensable for blocking differentiation in the presence of the HD The Pbx1 CH alone when fused to E2a has been reported to mediate ®broblast transformation . We tested the biochemical and myeloid immortalizing potential of Pbx1 containing the CH but lacking the HD. E2a-Pbx1D 487 ± 690 and E2a-Pbx1D 578 ± 690 failed to bind DNA cooperatively with Hox proteins (Figure 4b , lanes 5 and 6), failed to activate transcription cooperatively with Hox proteins, and failed to immortalize myeloblasts (Figure 4a ). E2a-Pbx1D 487 ± 690 and E2a-Pbx1D 578 ± 690 are presumed to be expressed in myeloid progenitors at levels commensurate with that of wild-type E2a-Pbx1 because their abundance after G418-selection in NIH3T3 ®broblasts is equal to that of wild-type E2a-Pbx1 (Figure 4c, lanes 4 and 5 vs lane 1) . The CH is therefore insucient for myeloid immortalization and the HD is essential.
The CH contains both a 3 10 helix (residues 690 ± 692) and an a-helix (694 ± 699) that pack against the HD (Piper et al., 1999) and increase its DNA-binding anity . Earlier we found that termination before (E2a-Pbx1 700Term ) or elimination of (E2a-Pbx1 694Term ) the a-helix did not disrupt myeloid immortalization. E2a-Pbx1 691Term was made to disrupt the 3 10 helix and therein examine its function. E2a-Pbx1 691Term formed heterodimers with HoxA5 and HoxB7 that were less stable than those formed by E2a-Pbx1 700Term or E2a-Pbx1 694Term ( Figure  5a , lanes 4 vs 2 and 3; lanes 10 vs 8 and 9; lanes 15 vs 13 and 14; lanes 20 vs 18 and 19). E2a-Pbx1 691Term retained signi®cant heterodimerization ability with Hox proteins on TGATTTAT ± heterodimers of E2a-Pbx1 with HoxA5, HoxB7, HoxB8 or HoxC8 exhibited orates of 110, 130, 125, and 100 min, respectively, while those containing E2a-Pbx1 691Term had o-rates of 23, 14, 10, and 25 min. Cooperativity with E2a-Pbx1 691Term was dependent on the Hox W-PIM, as mutation of the esssential tryptophan in the W-PIM of HoxA5 or HoxB8 strongly suppressed cooperative DNA-binding with E2a-Pbx1 (Figure 5b , lanes 1 vs 3, and 5 vs 7, respectively), and eliminated it with E2a-Pbx1 691Term (lane 2 vs 4, and 6 vs 8, respectively).
E2a-Pbx1 691Term retained Hox-dependent transcriptional activation through 66TGATTTAT (Figure 4a ) and immortalized myeloblasts. These myoblasts were GM-CSF-dependent, exhibited myeloid-speci®c nuclear morphology and azurophilic granules, and contained less than 1% of cells exhibiting a`donut' nuclear morphology indicative of neutrophilic dierentiation, demonstrating that a strong dierentiation block is maintained in the absence of the 3 10 helix. However, their cell cycle was distinctly longer (41 h) than those Figure 4 Abilities of E2a-Pbx1 and mutants of E2a-Pbx1 to activate transcription, immortalize myeloid progenitors, and induce foci on NIH3T3 cells. (a) Transactivation and transformation properties of wild-type and mutant E2a-Pbx1b proteins. nd; not determined. a; protein detectable only at very low levels in stabily-expressing NIH3T3 ®broblasts. The conclusion that E2a-Pbx1 D487 ± 690 and Pbx1 D578 ± 690 fail to activate reporter gene transcription because they lack their HD rather than because they are expressed at extremely low levels is based on the observation that their stability is equal to that of wild-type E2a-Pbx1 in NIH3T3 ®broblasts (c). immortalized by E2a-Pbx1 or by E2a-Pbx1 694Term (22 h), and they failed to proliferate in IL3 while those transformed by all other versions of E2a-Pbx1 responded well to IL3. Thus, the 3 10 helix contributes to a subset of the phenotypic properties of myeloblasts immortalized by E2a-Pbx1.
Hox-independent transcriptional activation through TGATTGAT correlates with the ability of E2a-Pbx1 to bind DNA as a homodimer Deletion of the CH abolished homodimerization on TGATTGATTTGAT of both Pbx1 (Figure 3c , lanes 14 and 15 vs lane 13) and E2a-Pbx1 (Figure 3d , lanes 7 ± 9 vs 10) and abolished transcriptional activation on 66TGATTGAT (Figure 4a) . A dierent mutant, E2a-Pbx1 D487 ± 578 , which lacks much of the Pbx dimerization motif, homodimerized weakly on TGATT-GATTTGAT (Figure 3d , lane 1) and activated transcription poorly on 66TGATTGAT (Figure 4a) . Surprisingly, HD mutations E28R and E28RE29R provided additional evidence for a homodimeric mechanism of activation through 66TGATTGAT. Both mutants failed to homodimerize on TGATT-GATTTGAT (Figure 3a lane 10 and not shown) and failed to activate transcription autonomously through 6xTGATTGAT (Figure 4a , and data not shown). Therefore, the eects of mutations within three distinct Pbx1 domains ± N-terminal to the HD, within the HD, and C-terminal to the HD ± support a homodimeric mechanism of transcriptional activation of TGATTGAT. Each of these three categories of mutants retained signi®cant cooperative transactivation with Hox proteins and immortalized myeloid progenitors, suggesting that homodimeric activation by E2a-Pbx1 is dispensable for myeloid immortalization, and that heterodimerization with Hox proteins may be essential.
The CH and inhibitory switch mediate clone-specific fibroblast transformation
There are con¯icting reports concerning the ability of DNA-binding and HD mutants of E2a-Pbx1 to transform NIH3T3 ®broblasts. While we reported that both E2a-Pbx1 694Term and E2a-Pbx1 626Term transform NIH3T3 cells , others demonstrated that truncation of the CH or any sequences including the CH (e.g. at residue 627) abrogates NIH3T3 cell transformation (Monica et al., 1994) , and that the CH alone tethered to E2a transforms NIH3T3 cells . Clonal variation in NIH3T3 ®broblasts can account for at least some of these discrepancies. While terminations within the ahelical portion of the CH (E2a-Pbx1 700T , E2a-Pbx1 694T ) as well as preceding the HD (E2a-Pbx1 627Term ) induce overt focus formation in clone 13 ®broblasts, they have little or no eect in close 8 ®broblasts (Figure 6 ). Binding of the IH to the Pbx HD may explain the puzzling observation that fusions of E2a with mutually exclusive Pbx1 domains ± that preceding the HD and that following the HD ± are both capable of transforming NIH3T3 ®broblasts. Both these regions can bind the Pbx1 HD and both may use binding to the HD's of dierentially expressed endogenous Pbx proteins as their transforming mechanisms.
Discussion

A partner-derepressed inhibitory switch regulates DNA-binding by Pbx proteins and E2a-Pbx1
Here, we demonstrate that intrinsic DNA-binding by the Pbx1 HD is repressed by the IH. We propose that the IH binds the minimal 63 residue HD because (1) it blocks DNA-binding by the minimal HD and (2) a mutation within the HD (E28R) abrogates IH function. The IH could either mask the DNA-binding surface of the HD or alter HD structure so as to destabilize the HD-DNA complex without blocking access of DNA to the binding pocket. Derepression of IH function occurs during cooperative DNA-binding and requires addition of dierent portions of Nterminal sequences, depending on the identity of the heterodimerizing partner. In the case of Prep1, exactly the same N-terminal sequences are required for DNAindependent binding to Pbx1 as are required for heterodimerization with Pbx1, suggesting that binding of partners to N-terminal sequences of Pbx1 may be a common requirement to derepress IH function, and indicating that the minimal N-terminal HD extensions required for homodimerization of Pbx (to Y168) and heterodimerization with Hox proteins (to D55) may delineate such interaction surfaces. O-rate analysis supports the possibility that Hox proteins use surfaces distinct from the P-PIM to contact Pbx1 N-terminal to its HD, as heterodimers of Hox proteins with fulllength Pbx1 are three times as stable as those formed with Pbx1 D232 ± Q347 .
Both the a subunit of PEBP2/CBF and the Ets family of transcription factors also use autoinhibitory sequences to block intrinsic DNA-binding and exhibit heterodimer-induced derepression of DNA-binding. In full-length Ets-1, domains on either side of the minimal DNA-binding domain function in concert to inhibit DNA-binding (Wasylyk et al., 1992) by destabilizing the protein-DNA complex, not by masking the DNAbinding surface (Jonsen et al., 1996) . In the case of the a subunit of PEBP2/CBF (also called PEBP2aB1/ AML1), DNA-binding by the Runt domain is inhibited by 109 adjacent C-terminal residues. Interaction of the b-subunit with the RUNT domain relieves the mechanism that inhibits DNA-binding (Kanno et al., 1998) . Interestingly, the ability of the a subunit of PEBP2 to cooperate with Ets-1 in transcriptional activation of the b subunit of the T-cell receptor requires mutual derepression of mechanisms blocking DNA-binding by both subunits, and is mediated by interaction of the two inhibitory domains (Kim et al., 1999) . This mechanism parallels the proposed heterodimerization mechanism with Pbx1, where binding of partners to a domain adjacent to the IH derepresses DNA-binding inhibition. Interestingly, in Ets-1, the secondary structure of an a-helix involved in repressing DNA binding becomes disrupted when Ets-1 binds DNA while the structure of the DNA-binding domain remains unaltered (Petersen et al., 1995) . A similar mechanism could also occur in Pbx1, where the structure of the IH is altered coincident with heterodimerization.
The inhibitory switch may cooperate with nuclear export sequences in dictating intracellular distribution of Pbx proteins
In some Drosophila S2 cell lines, inclusion of 52 residues N-terminal of the HD ± which contains both the IH and Pbx-dimerization motifs ± prevents nuclear localization (Abu-Shaar et al., 1999) . The fact that Leptomycine B, which blocks the CRM1/exportin1-related export pathway, also inhibits cytosolic localization of Exd, suggests these sequences mediate active nuclear export rather than passive inhibition of nuclear localization mediated by the NLS within the HD. These Pbx1 sequences, however, contain no leucine repeat sequence indicative of direct targets for nuclear export by CRM1/exportin1, and in other Drosophila S2 cell lines, addition of these same 52 residues fails to prevent nuclear localization (Berthelsen et al., 1999) . The derepression switch may contribute to this more complex mechanism regulating Pbx subcellular location. In addition to blocking DNA-binding, the IH could mask the function of the NLS in the Pbx1 HD, similar to the example of intermolecular masking of the p65 NLS by IkappaB in regulation of nuclear NF-kB activity (Ganchi et al., 1992) . This would account for the fact that in the absence of a partner, the nuclear export signal is dominant over the NLS. A partnerinduced conformational change could alter IH conformation, expose the NLS, and permit nuclear import. Because phosphorylation of transcription factors, such as yeast Pho4 regulates nuclear import/export (Kaman et al., 1998; Komeili and O'Shea, 1999) , it is also important to consider the roles of multiple potential phosphorylation sites that¯ank the IH. Phosphorylation of MAP-KAP kinase sites (S187, S202, and S209; consensus; I/L/M-X-R-X-X-S) or of a MAP kinase site (S193, consensus: P-X-S/T-P) could provide another mechanism for regulating the subcellular distribution and DNA-binding potential of Pbx1 and Pbx family proteins. Indeed, nuclear export of the MAPKAP kinase-2 substrate, p38, occurs in a complex with MAPKAP kinase (Ben-Levy et al., 1998) , and nuclear export of MAPKAP kinase itself is prevented by Leptomycin B (Engel et al., 1998) . A link between phosphorylation and Exd-dependent gene expression does occur in Drosophila, where transcriptional activation of Labial by Decapentaplegic (DPP), a member of the TGF-b family of signaling molecules that activate serine-threonine kinases, requires an enhancer element that binds Exd-Labial (Grieder et al., 1997) . DPP activity is also required for nuclear localization of Exd (Rieckhof et al., 1997) . Analysis of Pbx1 phosphorylation during cell division and dierentiation may provide further insights into the complex regulatory function of this region of Pbx proteins.
The inhibitory switch model in conjunction with mutational analysis suggests Hox proteins or other factors that bind the Pbx1 HD are essential partners in myeloid immortalization by E2a-Pbx1
A common theme is that negative regulatory domains in protooncoproteins are either dispensable or must be eliminated for the genesis of their cognate oncoproteins. This is true not only for regulation of catalytic activity, as occurs in the genesis of tyrosine protein kinase oncoproteins, but also for regulation of DNA-binding, as occurs in the Ets protein encoded by avian leukemia virus E26. The E26 Ets protein contains a deletion of Cterminal sequences that inhibit DNA-binding (Leprince et al., 1983) . The IH of Pbx1 illustrates another such example of a negative regulatory sequence dispensable both for myeloid immortalization as well as for human pre-B cell leukemogenesis (Numata et al., 1993) . The dispensable nature of the P-PIM motif both in myeloid immortalization and in human pre-B cell leukemogenesis furthermore indicates that speci®c Pbx-Pbx interactions are unnecessary. What does the dispensable nature of these sequences indicate about the mechanism of myeloid immortalization by E2a-Pbx1? Our model suggests that heterodimer partners of E2a-Pbx1 are required to permit active DNA-binding and to target E2a-Pbx1 to physiologically relevant DNA-motifs. Despite removal of all Pbx sequences on either side of the HD, E2a-Pbx1 retains its ability to target genes required for myeloid immortalization, suggesting that immortalization requires partners that interact with the Pbx1 HD, and implicating Hox proteins or other factors that bind the HD as essential cofactors. This hypothesis is consistent with observations that transformation by Hox proteins is also dependent on Pbx proteins. Fibroblast transformation by HoxB3 and HoxB4 requires Pbx coexpression (Krosl et al., 1998) , and the W-PIM is required for ®broblast transformation by NUP98-HoxA9 (Kasper et al., 1999) , implicating a Pbxdependent mechanism. Our mutual analysis of the CH and the HD also support the possibility that Hox proteins function as cofactors in myeloid immortalization by E2a-Pbx1. Deletion of the C-terminal 3 10 helix and a-helix, or HD mutation E28RE29R disrupted Hoxindependent transactivation on TGATTGAT but did not prevent either Hox-dependent activation on TGATTTAT or myeloid immortalization. In an eort to disrupt Hox-dependent activation on TGATTTAT motifs we introduced mutations E28R and E28RE29R into the D487 ± 623 version of E2a-Pbx1; however, both these proteins still exhibited robust cooperative transcriptional activation with Hox proteins on TGATT-TAT motifs. Ultimately, proving Hox-dependence of myeloid immortalization by E2a-Pbx1 will require introductions of speci®c mutations within the HD that disrupt interaction with the W-PIM and determination of whether such mutations prevent myeloid immortalization by E2a-Pbx1.
Materials and methods
Construction of recombinant plasmids
All cDNA's used in coupled transcription/translation were cloned in pGEM3z, pGEM3zf-, or pGEM4z (Promega). Wild-type and mutant versions of E2a-Pbx1 were cloned in the EcoR1 site of pMSCV2.1. This vector was used for subsequent assessment of biochemical activities by cotransfection, as well as for generation of retrovirus used to infect primary mouse marrow and NIH3T3 ®broblasts.
Mutagenesis
Site directed mutations were created using the Muta-gene phagemid in vitro mutagenesis kit (Biorad) according to the manufacturers protocol. All mutations were veri®ed by sequence analysis. Deletions were created by introducing two inframe MluI sites and excising intervening sequences, resulting in derivatives that contain the TR dipeptide at each excision junction. Amino terminal deletion mutants of Pbx1 were generated by PCR.
In vitro transcription/translation
Coupled transcription/translation was performed in vitro using the Promega TNT Coupled Reticulocyte Lysate System in accordance with manufacturer's protocol using SP6 polymerase.
Electrophoretic mobility shift assays (EMSA)
Double-stranded oligonucleotides were labeled with g-32 P-ATP to equal speci®c activities by phosphorylation of a common reverse oligonucelotide that was annealed to the 3' portion of oligonucleotides containing dierent DNA-binding motifs, ®lled in using dNTP's and Klenow polymerase, and isolated after separation through 15% acrylamide gels run in 0.56TBE (27 mM Tris; 27 mM boric acid; 0.6 mM EDTA). For EMSA, 20 000 c.p.m. of probe was incubated with 3 ± 6 ml of in vitro translated proteins in the presence of 1 mg of poly (dI:dC) in a buer containing 10 mM Tris (pH 7.5), 1 mM EDTA, 1 mM DTT, 0.1% NP-40, and 5% glycerol for 30 min at room temperature. Complexes were separated by electrophoresis in 5.0% acrylamide gels formed and run in 0.66TBE (27 mM Tris; 27 mM boric acid; 0.6 mM EDTA). Protein-DNA complexes were visualized by autoradiography and quantitated using a Bio-Rad GS-250 Molecular Imager. Unless otherwise noted, equal molar amounts of mutant and wild-type Pbx or E2a-Pbx1 proteins were added as assayed by parallel transcription translation reactions performed in the presence of 35 S-methionine, followed by quantitation of proteins resolved by SDS-gel electrophoresis using a BioRad GS-250 Molecular Imager. The doubled-stranded, unlabeled oligonucleotide (TCACGGTGATTTATGAGC-GACTGCTCGG) was used for o-rate analysis.
Transfections and luciferase assays NIH3T3 cells were dispersed on 6-well plates 24 h prior to transfections in Dulbecco's modi®ed Eagles medium containing 10% fetal bovine serum (FBS). A mixture of reporter and expression plasmids were introduced using lipofectamine (Gibco-BRL) according to the manufacturers speci®cations.
Cells were harvested 40 ± 48 h post transfection and luciferase assays performed, and luciferase abundance normalized to an internal control of renilla production using a dual luciferase reporter system (Promega). Nalm-6 pre-B cells were transfected using electroporation, luciferase production measured 36 h post-transfection and normalized to renilla controls.
Western blotting
Proteins in NIH3T3 cells and primary myeloblast populations stabily expressing E2a-Pbx1 were dissolved in Laemmli sample buer and boiled for 5 min. Proteins in 5610 5 cells were resolved by electrophoresis through 12.5% SDS polyacrylamide gels, transferred to a PVDF-Plus membrane, and detected immunologically with mouse anti-human E12/ E47 monoclonal antibody G193-86 (Pharmingen). Detection was also performed using monoclonal Yae (Santa Cruz Biotechnology), which bound the upper but not the lower form of E2a-Pbx1.
Marrow assays
Marrow was harvested from femurs and tibias of Balb/c female mice, and progenitors puri®ed by centrifugation through Ficoll-Paque (Pharmacia), as described (Kamps and Baltimore, 1993) . 1610 6 progenitors were transferred to each well of a 6-well tissue culture plate, incubated 1.0 h with 1 ml of E2a-Pbx1 retrovirus containing 5610 5 G418-resistance units, and 1 ml of Marrow Culture Medium (MCM; 500 mls RPMI1640, 10% FBS, 16antibiotics [Penicillin, Streptomycin] , 16glutamine, 16 units/ml GM-CSF) was added. Polybrene was added to 8 mg/ml. After 1 h, 6 ml of MC media was added to dilute the polybrene to 2 mg/ ml, and the infection was allowed to proceed 3 days. After 3 days, 4 ml medium was removed and replaced with 4 ml fresh MCM. Non-adherent cells were transferred every 7 days to new plates. Three to fourteen days after infection, cultures contained predominantly dierentiated, adherent macrophages, dierentiated non-adherent neutrophils, and proliferating non-adherent myeloid progenitors. Populations comprised of predominantly myeloid progenitors arose within 21 days for cells infected with all forms of E2a-Pbx1 that elicited immortalization with the exception of those infected with E2a-Pbx1 691Term , which arose within 30 days due to their protracted doubling time (42 vs 22 h).
